| Drug Name: | Cefacetrile (10206-21-0) |
|---|---|
| PubChem ID: | 91562 |
| SMILES: | CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CC#N)SC1)C(=O)O |
| InchiKey: | RRYMAQUWDLIUPV-BXKDBHETSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 339.329 |
| LogP | : | -0.79822 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 7 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 136.8 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Furosemide (54-31-9) | Nephrotoxicity | Antagonistic | Cefacetrile is nephrotoxic, but why this should be increased by furosemide is not understood. It may possibly be related to a reduction in its clearance | Possible interaction between cephacetrile and frusemide in rabbits and rats |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|